What is the appropriate dosing range for a continuous midazolam (Versed) infusion for sedation in a 9-year-old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Midazolam Continuous Infusion Dosing for Sedation in 9-Year-Olds

For continuous midazolam infusion sedation in a 9-year-old child, start with a loading dose of 0.05-0.2 mg/kg over 2-3 minutes, followed by a continuous infusion starting at 1 mcg/kg/min (0.06 mg/kg/hr), titrating up by 1 mcg/kg/min increments every 15 minutes as needed, with a maximum of 5 mcg/kg/min (0.3 mg/kg/hr). 11111

Dosing Algorithm

Initial Loading Dose

  • 0.05-0.2 mg/kg IV over 2-3 minutes in intubated patients 22
  • For non-intubated patients requiring procedural sedation: 0.025-0.05 mg/kg initial dose, with total dose up to 0.4 mg/kg (usually not exceeding 10 mg) 11111

Continuous Infusion

  • Starting rate: 1 mcg/kg/min (0.06 mg/kg/hr) 11111
  • Titration: Increase by 1 mcg/kg/min every 15 minutes until desired sedation achieved 11111
  • Maximum rate: 5 mcg/kg/min (0.3 mg/kg/hr) 11111

Critical Safety Considerations

Respiratory Monitoring Requirements

You must have continuous pulse oximetry and be prepared to provide respiratory support immediately. 111113 The most serious risk is respiratory depression leading to apnea, particularly when:

  • Combined with opioids or other CNS depressants (synergistic effect requiring dose reduction) 11111
  • Patient is non-intubated 22
  • Higher doses are used 11111

Titration Principles

Wait 2-3 minutes between bolus doses to allow peak CNS effect before administering additional medication. 1111122 Midazolam takes approximately 3 times longer than diazepam to achieve peak EEG effects, making slow titration essential to avoid oversedation. 11111

Dose Adjustments

Reduce doses by 50% or more when:

  • Co-administering opioids or other sedatives 1111122
  • Patient has hepatic or renal impairment 22
  • Patient is debilitated or higher ASA class 22

Context-Specific Dosing

For Refractory Status Epilepticus

If standard therapies fail:

  • Loading dose: 0.15-0.2 mg/kg IV 11111
  • Continuous infusion: Start at 1 mcg/kg/min, increase by 1 mcg/kg/min every 15 minutes 11111
  • Maximum: 5 mcg/kg/min 11111

For Procedural Sedation (Non-Intubated)

  • Initial: 0.025-0.05 mg/kg over 2-3 minutes 11111
  • Additional increments: 1 mg at 2-minute intervals 11111
  • Total dose: Usually does not exceed 10 mg 11111

Common Pitfalls to Avoid

  1. Inadequate monitoring: Continuous pulse oximetry is mandatory; have resuscitation equipment immediately available 322

  2. Too-rapid administration: Always administer over 2-3 minutes and wait for peak effect before redosing 1111122

  3. Failure to reduce dose with opioids: The combination creates synergistic respiratory depression requiring 50% dose reduction 1111122

  4. Paradoxical agitation: Occurs especially in younger children; if this happens, exercise caution before continuing 11111

  5. Prolonged infusions without weaning plan: For infusions >7 days, conversion to enteral lorazepam may be needed to prevent withdrawal 444

Reversal Agent

Have flumazenil immediately available for life-threatening respiratory depression, though note it will also reverse anticonvulsant effects if used for seizures. 11111

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.